Local pharmaceutical manufacturer targets global market with first shipment
Health & Science
By
David Njaaga
| Sep 22, 2024
A local pharmaceutical manufacturer is set to enhance Kenya’s global presence through new exports.
SQUARE Pharmaceuticals marked a milestone with its first shipment from the Athi River plant on Friday.
The flag-off ceremony included officials from SQUARE Pharmaceuticals Kenya and Export Processing Zones Authority (EPZA) Director Dr. Iruki Kailemia.
The shipment consisted of 5,500 boxes of Angilock tablets, a medication for high blood pressure that combines two ingredients to help control blood pressure levels. Somalia will be the initial destination.
“This achievement reflects our dedication to providing high-quality healthcare solutions,” Kailemia said, noting plans to supply other African and European countries from the plant.
READ MORE
Macadamia traders clash over AFA's alleged bias
47 ships reroute to Suez Canal since Feb
UAE investor inks Sh104b deal to expand Galana Kulalu project
Troubled Uchumi's creditors to know fate of their billions
Why tourism is Kenya's best bet to accelerate economic growth
BAT to pay Sh50 dividend despite 19pc profit dip
Appetite for Kenya's 'green gold' spawns new crop of millionaires
Policy Statement promises nothing unusual in CS Mbadi's first Budget
UNGA President Yang backs Equity's plan to boost youth innovation
Why you may not escape paying toll fees on major roads and highways
The firm has operated in Kenya since 2004, with its manufacturing facility opening in 2023.
Kailemia said the export will boost confidence in Kenyan-made pharmaceuticals among local healthcare professionals.
'This export demonstrates that local pharmaceuticals can meet international standards,” he added.
The company employs 250 local workers and plans to increase the number to 1,000 as operations grow, with plans for a line of liquid medications and injections.